Biotextiles Global Market – Forecast to 2023

Publishing Date : September, 2017
Report Code : HCMD0150
Price:
Single license $4,950
Site license $6,750
Global license $9,000


Note: The report would be dispatched after confirmation of payment

Biomedical textiles are one of the fastest growing fields in technical textile industry. Biomedical textiles can be categorized into two types i.e. Medical textiles and Biotextiles. Medical textiles market include products such as wound dressing, bandages, surgical dressing, medical clothing, barrier fabrics, protective clothing, surgical masks, sterile scrubs, etc. The BioTextiles are the textiles composed of synthetic or natural fibres designed specifically for implant procedures where there performance depends on biocompatibility and biostability with tissue and biological fluids. BioTextiles are used as implantable fabrics or as components of implantable devices. BioTextiles are used in applications such as surgical mesh, stent grafts, surgical sutures, hernia repair fabrics, artificial skin, heart patch, heart valves, artificial tendons & ligaments, cosmetic surgery, tissue engineering, neurovascular conduits, etc.

This report concentrates on biotextiles that are used as implants or components of implantable devices. The non-implant textiles or devices are not considered in biotextiles global market report.

The biotextiles market is classified based on manufacturing techniques, materials, applications and geography. By manufacturing technique, the market is segmented into woven textiles, non-woven textiles, braided textiles and knitted textiles. By materials, the market is segmented into Non-bioabsorbable textiles and Bioabsorbable textiles. By application, biotextiles market is segmented into cardiovascular, orthopedic, gynaecology & urology, general surgery and other applications.

The BioTextiles global market is expected to grow at mid single digit CAGR to reach $7,390.4 million by 2023. Among the Biotextiles product by manufacturing technique, the braided textiles segment dominates the market by occupying a largest share and woven textiles segment is the fastest growing market from 2016 to 2023. In the BioTextiles applications, General surgery held XX% share in 2016 expected to grow at a CAGR of X% to reach $XX million by 2023. Cardiovascular segment is the fastest growing market with a strong CAGR of X% from 2016 to 2023.

The Biotextiles global market based on geography is divided into North America, Europe, Asia-Pacific and Rest of the world. North American region commanded the largest revenue of $XX million in 2016 and expected to reach $XX million by 2023 at a CAGR of X%. A high prevalence of cardiovascular diseases (such as heart failure, cardiogenic shock, dilated cardiomyopathy, ventricular insufficiency, Valvular heart disease, and congenital heart diseases), orthopaedic disorders, increase in minimally invasive surgeries, cosmetic surgeries, growth in aging population and shortage of heart donor organs led the market growth in this region. However, Asia-Pacific is expected to grow at a CAGR of X% to reach $XX million by 2023 owing to the rapidly increasing aging population with high prevalence of cardiovascular diseases, orthopaedic diseases, improving healthcare infrastructure and rise in healthcare spending in the emerging countries, such as India and China.

The BioTextiles market is a highly fragmented market. Major players in BioTextiles market include ATEX Technologies, Inc. (U.S.), C.R.Bard, Inc. (U.S.), Confluent Medical Technologies (U.S.), Culzean Textile Solutions Ltd. (U.K.), Getinge Group (Maquet) (Sweden), J-Pac Medical (U.S.), Medtronic PLC (Ireland), Poly-Med, Inc. (U.S.), RUA Medical (U.K.), Terumo Corporation (vascutek) (Japan), U.S. Biodesign (U.S.), W.L. Gore & Associates Inc. (U.S.).

 

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:

  • North America
    • U.S.
    • Others
  • Europe
    • Germany
    • U.K.
    • France
    • Others
  • Asia-Pacific
    • Japan
    • China
    • India
    • Others
  • Rest of the World (RoW)
    • Brazil
    • Rest of Latin America
    • Middle East & Others
  • 1     EXECUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKEAWAYS
    • 2.2     REPORT DESCRIPTION
    • 2.3     MARKETS COVERED
    • 2.4     STAKEHOLDERS
    • 2.5     RESEARCH METHODOLOGY
      • 2.5.1     MARKET SIZE ESTIMATION
      • 2.5.2     MARKET BREAKDOWN AND DATA TRIANGULATION
      • 2.5.3     SECONDARY SOURCES
      • 2.5.4     PRIMARY SOURCES
      • 2.5.5     KEY DATA POINTS FROM SECONDARY SOURCES
      • 2.5.6     KEY DATA POINTS FROM PRIMARY SOURCES
      • 2.5.7     ASSUMPTIONS
  • 3     MARKET ANALYSIS
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING MARKET
      • 3.3.1     DRIVERS AND OPPORTUNITIES
        • 3.3.1.1     INCREASING AGING POPULATION
        • 3.3.1.2     INCREASING MINIMALLY INVASIVE SURGERY
        • 3.3.1.3     INCREASE IN ACCIDENTS AND SPORTS INJURIES
        • 3.3.1.4     TECHNOLOGICAL ADVANCEMENTS IN FIBRES AND FABRICATION METHODS
        • 3.3.1.5     INCREASING PREVALENCE OF LIFE STYLE DISEASES
        • 3.3.1.6     INCREASE IN CARDIOVASCULAR DISEASES AND HEART FAILURE
        • 3.3.1.7     DEMAND FOR ORTHOPEDIC IMPLANTS
        • 3.3.1.8     GROWTH IN EMERGING COUNTRIES
        • 3.3.1.9     GROWING HEALTHCARE BUDGETARY ALLOCATION
      • 3.3.2     RESTRAINTS AND THREATS
        • 3.3.2.1     LIMITATIONS OF BIOTEXTILES BASED PRODUCTS
        • 3.3.2.2     LACK OF SKILLED AND TRAINED PROFESSIONALS
        • 3.3.2.3     STRINGENT REGULATORY PROCESSES FOR APPROVAL
        • 3.3.2.4     REIMBURSEMENT ISSUES IN EMERGING COUNTRIES
    • 3.4     REGULATORY AFFAIRS
      • 3.4.1     INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
        • 3.4.1.1     ISO 9001: 2015 QUALITY MANAGEMENT SYSTEM
        • 3.4.1.2     ISO 13485 MEDICAL DEVICES
        • 3.4.1.3     ISO 10993 BIOLOGICAL EVALUATION OF MEDICAL DEVICES
        • 3.4.1.4     ISO 14644-1 CLEAN ROOM STANDARDS
      • 3.4.2     ASTM INTERNATIONAL STANDARDS
      • 3.4.3     U.S.
      • 3.4.4     CANADA
      • 3.4.5     EUROPE
      • 3.4.6     JAPAN
      • 3.4.7     CHINA
      • 3.4.8     INDIA
    • 3.5     PORTER’S FIVE FORCE ANALYSIS
      • 3.5.1     THREAT OF NEW ENTRANTS
      • 3.5.2     THREAT OF SUBSTITUTES
      • 3.5.3     BARGAINING POWER OF SUPPLIERS
      • 3.5.4     BARGAINING POWER OF BUYERS
      • 3.5.5     RIVALRY AMONG EXISTING COMPETITORS
    • 3.6     SUPPLY CHAIN ANALYSIS
    • 3.7     MARKET SHARE ANALYSIS BY MAJOR PLAYERS
    • 3.8     MATRIX OF BIOTEXTILES TYPE AND APPLICATIONS
    • 3.9     BIOTEXTILES COMPANY COMPARISON TABLE BY TEXTILE TYPES, APPLICATIONS AND MATERIALS
  • 4     BIOTEXTILES GLOBAL MARKET, BY MANUFACTURING TECHNIQUE
    • 4.1     INTRODUCTION
    • 4.2     WOVEN TEXTILES
    • 4.3     NON-WOVEN TEXTILES
    • 4.4     BRAIDED TEXTILES
    • 4.5     KNITTED TEXTILES
  • 5     BIOTEXTILES GLOBAL MARKET, BY MATERIAL
    • 5.1     INTRODUCTION
    • 5.2     NON-BIOABSORBABLE
    • 5.3     BIOABSORBABLE
  • 6     BIOTEXTILES GLOBAL MARKET, BY APPLICATION
    • 6.1     INTRODUCTION
    • 6.2     CARDIOVASCULAR
      • 6.2.1     STENTS
      • 6.2.2     STENT GRAFTS
      • 6.2.3     HEART VALVE REPLACEMENT
      • 6.2.4     HEART VALVE REPAIR
      • 6.2.5     OTHERS
    • 6.3     ORTHOPAEDIC
      • 6.3.1     ARTIFICIAL LIGAMENTS AND TENDONS
      • 6.3.2     SUTURES AND SUTURE ANCHORS
      • 6.3.3     OTHERS
    • 6.4     GYNAECOLOGY AND UROLOGY
      • 6.4.1     INCONTINENCE SLINGS
      • 6.4.2     PELVIC FLOOR REPAIR MESH
      • 6.4.3     OTHERS
    • 6.5     GENERAL SURGERY
      • 6.5.1     SUTURES
      • 6.5.2     HERNIA REPAIR MESH
      • 6.5.3     COSMETIC SURGERY
      • 6.5.4     OTHERS
    • 6.6     OTHER APPLICATIONS
  • 7     REGIONAL ANALYSIS
    • 7.1     INTRODUCTION
    • 7.2     NORTH AMERICA
      • 7.2.1     U.S.
      • 7.2.2     OTHERS
    • 7.3     EUROPE
      • 7.3.1     GERMANY
      • 7.3.2     U.K.
      • 7.3.3     FRANCE
      • 7.3.4     OTHERS
    • 7.4     APAC
      • 7.4.1     JAPAN
      • 7.4.2     CHINA
      • 7.4.3     INDIA
      • 7.4.4     OTHERS
    • 7.5     ROW
      • 7.5.1     BRAZIL
      • 7.5.2     REST OF LATIN AMERICA
      • 7.5.3     MIDDLE EAST AND OTHERS
  • 8     COMPETITIVE LANDSCAPE
    • 8.1     INTRODUCTION
  • 9     MAJOR COMPANIES
    • 9.1     ATEX TECHNOLOGIES, INC.
      • 9.1.1     OVERVIEW
      • 9.1.2     FINANCIALS
      • 9.1.3     PRODUCT PORTFOLIO
      • 9.1.4     KEY DEVELOPMENTS
      • 9.1.5     BUSINESS STRATEGY
      • 9.1.6     SWOT ANALYSIS
    • 9.2     C.R.BARD
      • 9.2.1     OVERVIEW
      • 9.2.2     FINANCIALS
      • 9.2.3     PRODUCT PORTFOLIO
      • 9.2.4     KEY DEVELOPMENTS
      • 9.2.5     BUSINESS STRATEGY
      • 9.2.6     SWOT ANALYSIS
    • 9.3     CONFLUENT MEDICAL TECHNOLOGIES
      • 9.3.1     OVERVIEW
      • 9.3.2     FINANCIALS
      • 9.3.3     PRODUCT PORTFOLIO
      • 9.3.4     KEY DEVELOPMENTS
      • 9.3.5     BUSINESS STRATEGY
      • 9.3.6     SWOT ANALYSIS
    • 9.4     FENNER PLC (SECANT GROUP LLC)
      • 9.4.1     OVERVIEW
      • 9.4.2     FINANCIALS
      • 9.4.3     PRODUCT PORTFOLIO
      • 9.4.4     KEY DEVELOPMENTS
      • 9.4.5     BUSINESS STRATEGY
      • 9.4.6     SWOT ANALYSIS
    • 9.5     GETINGE GROUP (MAQUET)
      • 9.5.1     OVERVIEW
      • 9.5.2     FINANCIALS
      • 9.5.3     PRODUCT PORTFOLIO
      • 9.5.4     KEY DEVELOPMENTS
      • 9.5.5     BUSINESS STRATEGY
      • 9.5.6     SWOT ANALYSIS
    • 9.6     MEDTRONIC PLC
      • 9.6.1     OVERVIEW
      • 9.6.2     FINANCIALS
      • 9.6.3     PRODUCT PORTFOLIO
      • 9.6.4     KEY DEVELOPMENTS
      • 9.6.5     BUSINESS STRATEGY
      • 9.6.6     SWOT ANALYSIS
    • 9.7     RUA MEDICAL
      • 9.7.1     OVERVIEW
      • 9.7.2     FINANCIALS
      • 9.7.3     PRODUCT PORTFOLIO
      • 9.7.4     KEY DEVELOPMENTS
      • 9.7.5     BUSINESS STRATEGY
      • 9.7.6     SWOT ANALYSIS
    • 9.8     TERUMO CORPORATION (VASCUTEK LTD.)
      • 9.8.1     OVERVIEW
      • 9.8.2     FINANCIALS
      • 9.8.3     PRODUCT PORTFOLIO
      • 9.8.4     KEY DEVELOPMENTS
      • 9.8.5     BUSINESS STRATEGY
      • 9.8.6     SWOT ANALYSIS
    • 9.9     US BIODESIGN, LLC
      • 9.9.1     OVERVIEW
      • 9.9.2     FINANCIALS
      • 9.9.3     PRODUCT PORTFOLIO
      • 9.9.4     KEY DEVELOPMENTS
      • 9.9.5     BUSINESS STRATEGY
      • 9.9.6     SWOT ANALYSIS
    • 9.10     W.L.GORE & ASSOCIATES, INC.
      • 9.10.1     OVERVIEW
      • 9.10.2     FINANCIALS
      • 9.10.3     PRODUCT PORTFOLIO
      • 9.10.4     KEY DEVELOPMENTS
      • 9.10.5     BUSINESS STRATEGY
      • 9.10.6     SWOT ANALYSIS

      LIST OF TABLES

      • TABLE 1     BIOTEXTILES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 2     BIOTEXTILES GLOBAL MARKET REVENUE, BY MANUFACTURING TECHNIQUE, (2015-2023) ($MN)
      • TABLE 3     WOVEN TEXTILES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 4     NON-WOVEN TEXTILES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 5     BRAIDED TEXTILES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 6     KNITTED TEXTILES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 7     BIOTEXTILES GLOBAL MARKET REVENUE, BY MATERIAL, (2015-2023) ($MN)
      • TABLE 8     NON-BIOABSORBABLE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 9     BIOABSORBABLE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 10     BIOTEXTILES GLOBAL MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
      • TABLE 11     CARDIOVASCULAR GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 12     CARDIOVASCULAR GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 13     STENTS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 14     STENT GRAFTS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 15     HEART VALVE REPLACEMENT GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 16     HEART VALVE REPAIR GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 17     OTHERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 18     ORTHOPAEDIC GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 19     ORTHOPAEDIC GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 20     ARTIFICIAL LIGAMENTS AND TENDONS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 21     SUTURES AND SUTURE ANCHORS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 22     OTHERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 23     GYNAECOLOGY AND UROLOGY GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 24     GYNAECOLOGY AND UROLOGY GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 25     INCONTINENCE SLINGS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 26     PELVIC FLOOR REPAIR MESH GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 27     OTHERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 28     GENERAL SURGERY GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 29     GENERAL SURGERY GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 30     SUTURES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 31     HERNIA REPAIR MESH GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 32     COSMETIC SURGERY GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 33     OTHERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 34     OTHER APPLICATIONS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 35     BIOTEXTILES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 36     NORTH AMERICAN BIOTEXTILES MARKET REVENUE, BY MANUFACTURING TECHNIQUE, (2015-2023) ($MN)
      • TABLE 37     NORTH AMERICAN BIOTEXTILES MARKET REVENUE, BY MATERIAL, (2015-2023) ($MN)
      • TABLE 38     NORTH AMERICAN BIOTEXTILES MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
      • TABLE 39     NORTH AMERICAN CARDIOVASCULAR MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 40     NORTH AMERICAN ORTHOPAEDIC MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 41     NORTH AMERICAN GYNAECOLOGY & UROLOGY MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 42     NORTH AMERICAN GENERAL SURGERY MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 43     NORTH AMERICAN BIOTEXTILE MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
      • TABLE 44     EUROPE BIOTEXTILES MARKET REVENUE, BY MANUFACTURING TECHNIQUE, (2015-2023) ($MN)
      • TABLE 45     EUROPE BIOTEXTILES MARKET REVENUE, BY MATERIAL, (2015-2023) ($MN)
      • TABLE 46     EUROPE BIOTEXTILES MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
      • TABLE 47     EUROPE CARDIOVASCULAR MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 48     EUROPE ORTHOPAEDIC MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 49     EUROPE GYNAECOLOGY & UROLOGY MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 50     EUROPE GENERAL SURGERY MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 51     EUROPE BIOTEXTILES MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
      • TABLE 52     APAC BIOTEXTILES MARKET REVENUE, BY MANUFACTURING TECHNIQUE, (2015-2023) ($MN)
      • TABLE 53     APAC BIOTEXTILES MARKET REVENUE, BY MATERIAL, (2015-2023) ($MN)
      • TABLE 54     APAC BIOTEXTILES MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
      • TABLE 55     APAC CARDIOVASCULAR MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 56     APAC ORTHOPAEDIC MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 57     APAC GYNAECOLOGY & UROLOGY MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 58     APAC GENERAL SURGERY MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 59     APAC BIOTEXTILES MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
      • TABLE 60     ROW BIOTEXTILES MARKET REVENUE, BY MANUFACTURING TECHNIQUE, (2015-2023) ($MN)
      • TABLE 61     ROW BIOTEXTILES MARKET REVENUE, BY MATERIAL, (2015-2023) ($MN)
      • TABLE 62     ROW BIOTEXTILES MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
      • TABLE 63     ROW CARDIOVASCULAR MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 64     ROW ORTHOPAEDIC MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 65     ROW GYNAECOLOGY & UROLOGY MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 66     ROW GENERAL SURGERY MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 67     ROW BIOTEXTILES MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
      • TABLE 68     COMPANY DEVELOPMENTS (ACQUISITIONS / APPROVALS / NEW PRODUCT LAUNCHES / AGREEMENTS / OTHERS)
      • TABLE 69     C.R.BARD: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 70     C.R.BARD: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
      • TABLE 71     C.R.BARD: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN)
      • TABLE 72     FENNER PLC: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 73     FENNER PLC: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
      • TABLE 74     FENNER PLC: TOTAL REVENUE, BY AEP SUB-SEGMENTS, (2015-2017) ($MN)
      • TABLE 75     FENNER PLC: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN)
      • TABLE 76     GETINGE GROUP: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 77     GETINGE GROUP: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
      • TABLE 78     GETINGE GROUP: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN)
      • TABLE 79     MEDTRONIC PLC: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 80     MEDTRONIC PLC: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
      • TABLE 81     MEDTRONIC PLC: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN)
      • TABLE 82     TERUMO CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 83     TERUMO CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 84     TERUMO CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)

      LIST OF FIGURES

      • FIGURE 1     BIOTEXTILES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • FIGURE 2     RESEARCH METHODOLOGY: BIOTEXTILES GLOBAL MARKET
      • FIGURE 3     BIOTEXTILES GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
      • FIGURE 4     BIOTEXTILES GLOBAL MARKET: FORECASTING MODEL
      • FIGURE 5     BIOTEXTILES GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
      • FIGURE 6     BIOTEXTILES GLOBAL MARKET SEGMENTATION
      • FIGURE 7     MARKET DYNAMICS
      • FIGURE 8     BIOTEXTILES GLOBAL MARKET: PORTER’S ANALYSIS
      • FIGURE 9     BIOTEXTILES GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
      • FIGURE 10     BIOTEXTILES GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016 (%)
      • FIGURE 11     BIOTEXTILES GLOBAL MARKET REVENUE, BY MANUFACTURING TECHNIQUE (2016 V/S 2023) ($MN)
      • FIGURE 12     WOVEN TEXTILES GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
      • FIGURE 13     NON-WOVEN TEXTILES GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
      • FIGURE 14     BRAIDED TEXTILES GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
      • FIGURE 15     KNITTED TEXTILES GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
      • FIGURE 16     BIOTEXTILES GLOBAL MARKET REVENUE, BY MATERIAL, (2016 V/S 2023) ($MN)
      • FIGURE 17     NON-BIOABSORBABLE GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
      • FIGURE 18     BIOABSORBABLE GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
      • FIGURE 19     BIOTEXTILES GLOBAL MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
      • FIGURE 20     CARDIOVASCULAR GLOBAL MARKET REVENUE, BY TYPE, (2016 V/S 2023) ($MN)
      • FIGURE 21     CARDIOVASCULAR GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
      • FIGURE 22     ORTHOPAEDIC GLOBAL MARKET REVENUE, BY TYPE, (2016 V/S 2023) ($MN)
      • FIGURE 23     ORTHOPAEDIC GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
      • FIGURE 24     GYNAECOLOGY AND UROLOGY GLOBAL MARKET REVENUE, BY TYPE, (2016 V/S 2023) ($MN)
      • FIGURE 25     GYNAECOLOGY & UROLOGY GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
      • FIGURE 26     GENERAL SURGERY GLOBAL MARKET REVENUE, BY TYPE, (2016 V/S 2023) ($MN)
      • FIGURE 27     GENERAL SURGERY GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
      • FIGURE 28     OTHER APPLICATIONS GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
      • FIGURE 29     BIOTEXTILES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN), CAGR (%)
      • FIGURE 30     NORTH AMERICA BIOTEXTILES REVENUE, BY TECHNIQUE/MATERIAL/APPLICATION (2016 V/S 2023) ($MN)
      • FIGURE 31     U.S. BIOTEXTILES MARKET REVENUE, BY TECHNIQUE/MATERIAL/APPLICATION (2016 V/S 2023) ($MN)
      • FIGURE 32     OTHERS BIOTEXTILES MARKET REVENUE, BY TECHNIQUE/MATERIAL/APPLICATION (2016 V/S 2023) ($MN)
      • FIGURE 33     EUROPE BIOTEXTILES MARKET REVENUE, BY TECHNIQUE/MATERIAL/APPLICATION (2016 V/S 2023) ($MN)
      • FIGURE 34     GERMANY BIOTEXTILES MARKET REVENUE, BY TECHNIQUE/MATERIAL/APPLICATION (2016 V/S 2023) ($MN)
      • FIGURE 35     U.K. BIOTEXTILES MARKET REVENUE, BY TECHNIQUE/MATERIAL/APPLICATION (2016 V/S 2023) ($MN)
      • FIGURE 36     FRANCE BIOTEXTILES MARKET REVENUE, BY TECHNIQUE/MATERIAL/APPLICATION (2016 V/S 2023) ($MN)
      • FIGURE 37     OTHERS BIOTEXTILES MARKET REVENUE, BY TECHNIQUE/MATERIAL/APPLICATION (2016 V/S 2023) ($MN)
      • FIGURE 38     APAC BIOTEXTILES MARKET REVENUE, BY TECHNIQUE/MATERIAL/APPLICATION (2016 V/S 2023) ($MN)
      • FIGURE 39     JAPAN BIOTEXTILES MARKET REVENUE, BY TECHNIQUE/MATERIAL/APPLICATION (2016 V/S 2023) ($MN)
      • FIGURE 40     CHINA BIOTEXTILES MARKET REVENUE, BY TECHNIQUE/MATERIAL/APPLICATION (2016 V/S 2023) ($MN)
      • FIGURE 41     INDIA BIOTEXTILES MARKET REVENUE, BY TECHNIQUE/MATERIAL/APPLICATION (2016 V/S 2023) ($MN)
      • FIGURE 42     OTHERS BIOTEXTILES MARKET REVENUE, BY TECHNIQUE/MATERIAL/APPLICATION (2016 V/S 2023) ($MN)
      • FIGURE 43     ROW BIOTEXTILES MARKET REVENUE, BY TECHNIQUE/MATERIAL/APPLICATION (2016 V/S 2023) ($MN)
      • FIGURE 44     BRAZIL BIOTEXTILES MARKET REVENUE, BY TECHNIQUE/MATERIAL/APPLICATION (2016 V/S 2023) ($MN)
      • FIGURE 45     REST OF LATIN AMERICA BIOTEXTILES MARKET REVENUE, BY TECHNIQUE/MATERIAL/APPLICATION (2016 V/S 2023) ($MN)
      • FIGURE 46     MIDDLE EAST AND OTHERS BIOTEXTILES MARKET REVENUE, BY TECHNIQUE/APPLICATION (2016 V/S 2023) ($MN)
      • FIGURE 47     KEY GROWTH STRATEGIES, (2015-2017)
      • FIGURE 48     SWOT: ATEX TECHNOLOGIES, INC.
      • FIGURE 49     SWOT: C.R.BARD
      • FIGURE 50     SWOT: CONFLUENT MEDICAL TECHNOLOGIES
      • FIGURE 51     SWOT: FENNER PLC
      • FIGURE 52     SWOT: GETINGE GROUP (MAQUET)
      • FIGURE 53     SWOT: MEDTRONIC PLC
      • FIGURE 54     SWOT: RUA MEDICAL
      • FIGURE 55     SWOT: TERUMO CORPORATION
      • FIGURE 56     SWOT: US BIODESIGN, LLC
      • FIGURE 57     SWOT: W.L. GORE & ASSOCIATES, INC.

      LIST OF COMPANIES MENTIONED

      • 1     ADVANCED MEDICAL SOLUTIONS GROUP PLC (RESORBA)
      • 2     AMNIVOR MEDICARE PVT. LTD.
      • 3     ARAN BIOMEDICAL LTD.
      • 4     ASPIDE MEDICAL
      • 5     ATEX TECHNOLOGIES, INC.
      • 6     BALLY RIBBON MILLS
      • 7     BIOSURFACES, INC.
      • 8     COLLAGEN MATRIX, INC.
      • 9     CONFLUENT MEDICAL TECHNOLOGIES
      • 10     CORTLAND COMPANY, INC.
      • 11     COUSIN BIOTECH SAS
      • 12     C.R.BARD, INC.
      • 13     CULZEAN TEXTILE SOLUTIONS LTD.
      • 14     DELFINGEN DE MARKTRODACH GMBH & CO. KG
      • 15     FENNER PLC (SECANT GROUP)
      • 16     FREUDENBERG & CO. KG
      • 17     GETINGE GROUP (MAQUET)
      • 18     INSPIREMD
      • 19     J-PAC MEDICAL
      • 20     LENZING PLASTICS GMBH CO KG
      • 21     MDB TEXINOV
      • 22     MEDTRONIC PLC
      • 23     MEISTER & CIE AG
      • 24     NIMESIS TECHNOLOGY
      • 25     NOVUS SCIENTIFIC INC.
      • 26     POLY-MED, INC.
      • 27     PROXY BIOMEDICAL LTD.
      • 28     ROYAL DSM N.V.
      • 29     RUA MEDICAL
      • 30     SERAG-WIESSNER GMBH & CO. KG
      • 31     SPECIALITY FIBERS & MATERIALS LTD
      • 32     SYNTHASOME INC.
      • 33     TEPHA MEDICAL DEVICES
      • 34     TERUMO CORPORATION (VASCUTEK)
      • 35     TEXTILE DEVELOPMENT ASSOCIATES, INC.
      • 36     THE ELECTROSPINNING COMPANY LTD.
      • 37     TISSUEGEN, INC.
      • 38     U.S. BIODESIGN
      • 39     W.L. GORE & ASSOCIATES INC.
      • 40     WOVEN ORTHOPEDIC TECHNOLOGIES, LLC.
      • 41     XIROS, LTD.
      • 42     ZEUS, INC.